To refer a patient to Connecticut Children’s, contact the OneCall team:

Diabetic Ketoacidosis

Pathway Background and Objectives

Diabetic Ketoacidosis (DKA) is a potentially fatal metabolic complication of uncontrolled diabetes mellitus. DKA consists of the biochemical triad of hyperglycemia, ketonemia and metabolic acidosis, resulting from absolute or relative insulin deficiency in the presence of an increase in counter regulatory hormones. Evolving treatment for diabetic ketoacidosis in specialized centers retains three basic elements: meticulous monitoring of vital signs and biochemical responses, provision of intravenous insulin, and replacement of fluids and electrolytes. Over the years, remarkable improvement has been made in the prognosis of DKA, due to clinical guidelines and well-constructed management protocols. This pathway aims to establish a clear, unambiguous written protocol, adapted to our local circumstances for appropriate triage and management of DKA. The objectives of this pathway are to:

  • Decrease variation in care for patients with DKA
  • Establish evidence-based care standards that are delivered in a timely manner
  • Monitor and improve outcomes for patients with DKA

Algorithm

Quality Metrics

Coming soon!

Educational Module

Coming soon!

Key References

Pathway Contacts:

 

Disclaimer

The clinical pathways in the above links have been developed specifically for use at Connecticut Children’s and are made available publicly for informational and/or educational purposes only. The clinical pathways are not intended to be, nor are they, a substitute for individualized professional medical judgment, advice, diagnosis, or treatment. Although Connecticut Children’s makes all efforts to ensure the accuracy of the posted content, Connecticut Children’s makes no warranty of any kind as to the accuracy or completeness of the information or its fitness for use at any particular facility or in any individual case.

View all Clinical Pathways >

Back to Top
Searching Animation
Searching